Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantation

Detalles Bibliográficos
Autores principales: Roy, V, Stewart, A K, Bergsagel, P L, Dispenzieri, A, Laumann, K, Allred, J, Lacy, M Q, Fonseca, R, Reeder, C B, Kumar, S, Rivera, C E, Gertz, M A, Buadi, F K, Hayman, S R, Rajkumar, S V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382664/
https://www.ncbi.nlm.nih.gov/pubmed/25794130
http://dx.doi.org/10.1038/bcj.2015.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382664/
https://www.ncbi.nlm.nih.gov/pubmed/25794130
http://dx.doi.org/10.1038/bcj.2015.23

Ejemplares similares